Hcw Biologics INC. (HCWB) — 10-Q Filings

All 10-Q filings from Hcw Biologics INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (5)

HCWB's Revenue Plummets Amidst License Suspension, Debt Restructuring — Nov 14, 2025 Risk: high
HCW Biologics Inc. (HCWB) reported a significant increase in net loss for the three months ended September 30, 2025, reaching $4,554,336, up from $3,902,288 in
HCW Biologics Files Q2 2025 10-Q — Aug 18, 2025 Risk: medium
HCW Biologics Inc. filed its 10-Q for the period ending June 30, 2025. The filing details various financial activities, including transactions related to conver
HCW Biologics Files Q1 2025 10-Q, Reports Subsequent Events — May 15, 2025 Risk: medium
HCW Biologics Inc. filed its Q1 2025 10-Q report on May 15, 2025, detailing operations for the period ending March 31, 2025. The company's business address is 2
HCW Biologics Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
HCW Biologics Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial position and operational highlights. Key financia
HCW Biologics Files Q2 2024 10-Q, Appoints New EVP — Aug 14, 2024 Risk: medium
HCW Biologics Inc. reported its financial results for the quarter ended June 30, 2024. The company's filing details its financial position, including assets lik

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX